Werewolf Therapeutics Sells Preclinical INDUCER and INDUKINE Platform Assets to EMD Serono for $28M Upfront, Plus $5M Upon Technology Transfer Completion

20 Aug 2026 · 20:11 UTC

Observed price moves

HOWL+21.03%15 min after this headline

MoveSurge carries market-moving headlines the moment they reach the wire, each one with what the price did next. We pay about $120,000 a month for the newswires behind this feed.